Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Testosterone sulfate)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004309 AN007173 Metabolic reprogramming by caloric restriction enhances acute-phase virologic control and reduces chronic inflammation in SIV-infected rhesus macaques Blood Rhesus monkey HIV Tulane National Biomedical Research Center LC-MS
ST004303 AN007160 Exercise intensity modulates the human plasma secretome and interorgan communication Blood Human Hypertension; Diabetes The Rockefeller University LC-MS
ST004207 AN006997 Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma Kidney Human, Mouse Cancer University of Cambridge LC-MS
ST004204 AN006991 The growth and virulence of S. aureus is inhibited by C. striatum by inhibiting its arginine biosynthesis pathway Bacterial cells Staphylococcus aureus Chronic rhinosinusitis Sun Yat-sen University LC-MS
ST004186 AN007232 Discovery and Validation of Metabolic Biomarkers for 'Liver Qi Stagnation' and 'Liver-Gallbladder Damp-Heat' Syndromes in Cholelithiasis: Blood untargeted Blood Human Gallstones First Affiliated Hospital of Dalian Medical University LC-MS
ST004153 AN006895 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004138 AN006861 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Autoimmune disease Hangzhou Xixi Hospital LC-MS
ST004138 AN006861 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Liver disease Hangzhou Xixi Hospital LC-MS
ST003636 AN005970 Individual glycemic responses to carbohydrates vary and reflect underlying metabolic physiology (metabolomics) Blood Human Cardiovascular disease Stanford University LC-MS
ST003636 AN005970 Individual glycemic responses to carbohydrates vary and reflect underlying metabolic physiology (metabolomics) Blood Human Diabetes Stanford University LC-MS
ST003408 AN005593 Untargeted analysis of urine samples in a Longitudinal analysis of environmental exposures in pregnancy. Urine Human Baylor College of Medicine LC-MS
ST003348 AN005484 An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - untargeted Blood Human First Affiliated Hospital of Dalian Medical University LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST003002 AN004930 The role of gut microbiota in muscle mitochondria function, colon health, and sarcopenia: from clinical to bench (2) Feces Human Sarcopenia Chinese University of Hong Kong GC-MS/LC-MS
ST002955 AN004852 Untargeted metabolomics analysis of plasma from viremic non-progressors (VNP), progressors, and healthy control (HC) patients using high-resolution, high-performance LC-MS/MS analysis. Blood Human HIV IrsiCaixa LC-MS
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center Other
ST002576 AN005611 Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) Blood Human Heart disease Boston University LC-MS
ST002576 AN005613 Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) Blood Human Heart disease Boston University LC-MS
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine LC-MS
ST002328 AN003798 Metabolome and transcriptome analysis of oral mucosa of HIV+ patients reveal a role for polyamine metabolic pathway in T cell dysfunction Saliva Human HIV Case Western Reserve University LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST001849 AN002994 Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) Blood Human COVID-19 Washington University in St. Louis LC-MS
ST001784 AN002895 Validation of the classifying model by OLA and CLO therapy cases Blood Mouse Hebei medical university LC-MS
ST001749 AN002850 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin-Madison LC-MS
ST001720 AN002803 Metabolomics Analysis of ACTG Cohort -Update (part-II) Blood Human HIV Wistar Institute LC-MS
ST001719 AN002802 Metabolomics Analysis of Philadelphia Cohort - Update (part-I) Blood Human HIV Wistar Institute LC-MS
ST000957 AN001571 Global metabolomics of human milk fractions Breast milk Human Obesity University of Florida LC-MS
ST000919 AN001507 Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics Blood Human University of Florida LC-MS
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000422 AN000670 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000666 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo